Literature DB >> 1434514

Characterization of phosphofructokinase-deficient canine erythrocytes.

J W Harvey1, M G Pate, Y Mhaskar, G A Dunaway.   

Abstract

Dogs homozygously affected with muscle-type phosphofructokinase (PFK) deficiency had about 20% of normal erythrocyte PFK activity and exhibited a compensated haemolytic anaemia. Erythrocyte glucose-6-phosphate and fructose-6-phosphate concentrations were increased and dihydroxyacetone phosphate and 2,3-bisphosphoglycerate values were below normal in affected dogs. Other intermediates distal to the PFK step were not significantly below normal and fructose-1,6-bisphosphate was even above normal. Erythrocyte ATP was higher than normal in affected dogs owing to the reticulocytes present. Abnormal adenylate metabolism was demonstrated by low ATP/AMP and ADP/AMP ratios and the inability to maintain ATP content when affected erythrocytes were incubated with cyanide. Glucose-1,6-bisphosphate content was normal, and fructose-2,6-bisphosphate content in affected canine erythrocytes was higher than normal. Studies of erythrocyte PFK isozymes revealed altered enzyme kinetic properties in affected dogs which appeared to be due to the loss of the M-type subunit.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1434514     DOI: 10.1007/bf01800017

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  34 in total

1.  The effect of phlebotomy on canine erythrocyte metabolism.

Authors:  J E Smith; N S Agar
Journal:  Res Vet Sci       Date:  1975-05       Impact factor: 2.534

2.  Fructose 2,6-bisphosphate and glucose 1,6-bisphosphate in rabbit erythroid cells during differentiation.

Authors:  C Gallego; R Bartrons; J Carreras
Journal:  FEBS Lett       Date:  1987-09-28       Impact factor: 4.124

3.  Glucose- and mannose-1,6-P2 as activators of phosphofructokinase in red blood cells.

Authors:  I A Rose; J V Warms
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

4.  A liver-type mutation in a case of pronounced erythrocyte phosphofructokinase deficiency without clinical expression.

Authors:  J Etiemble; J Simeon; H A Buc; C Picat; M Boulard; P Boivin
Journal:  Biochim Biophys Acta       Date:  1983-09-13

5.  Genetic defect in muscle phosphofructokinase deficiency. Abnormal splicing of the muscle phosphofructokinase gene due to a point mutation at the 5'-splice site.

Authors:  H Nakajima; N Kono; T Yamasaki; K Hotta; M Kawachi; M Kuwajima; T Noguchi; T Tanaka; S Tarui
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

6.  Determination of erythrocyte glucose 1,6-bisphosphate--a comparison of two methods using a centrifugal analyzer.

Authors:  D R Thorburn; P W Kuchel
Journal:  Clin Chim Acta       Date:  1987-04-30       Impact factor: 3.786

7.  Kinetic properties of erythrocyte phosphofructokinase in patients with type VII glycogenosis from two families--close similarity to liver type phosphofructokinase.

Authors:  T Shimizu; N Kono; I Mineo; S Sumi; K Nonaka; S Tarui; W Koyama
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency.

Authors:  S Vora; M Davidson; C Seaman; A F Miranda; N A Noble; K R Tanaka; E P Frenkel; S Dimauro
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

9.  Inherited phosphofructokinase deficiency in dogs with hyperventilation-induced hemolysis: increased in vitro and in vivo alkaline fragility of erythrocytes.

Authors:  U Giger; J W Harvey; R A Yamaguchi; P K McNulty; A Chiapella; E Beutler
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

10.  Inosine permeability and purine nucleoside phosphorylase activity as limiting factors for the synthesis of 2,3-diphosphoglycerate from inosine, pyruvate, and inorganic phosphate in erythrocytes of various mammalian species.

Authors:  J Duhm
Journal:  Biochim Biophys Acta       Date:  1974-03-20
View more
  1 in total

1.  Hemolysis, myopathy, and cardiac disease associated with hereditary phosphofructokinase deficiency in two Whippets.

Authors:  Karen Gerber; John W Harvey; Sara D'Agorne; Jonathan Wood; Urs Giger
Journal:  Vet Clin Pathol       Date:  2008-10-28       Impact factor: 1.180

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.